天目药业
(600671)
| 流通市值：20.83亿 | | | 总市值：20.84亿 |
| 流通股本：1.22亿 | | | 总股本：1.22亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 11,740,346.34 | 25,367,141.74 | 33,246,867.03 | 65,724,985.87 |
| 交易性金融资产 | - | - | 3,500,000 | - |
| 应收票据及应收账款 | 152,820,152.54 | 113,431,446.03 | 112,145,182.52 | 96,565,118.72 |
| 应收账款 | 152,820,152.54 | 113,431,446.03 | 112,145,182.52 | 96,565,118.72 |
| 应收款项融资 | 1,441,949.8 | 325,852.94 | 173,335.87 | 1,409,127.44 |
| 预付款项 | 7,300,284.06 | 2,978,010.75 | 7,411,332.89 | 2,295,767.16 |
| 其他应收款合计 | 1,671,418.2 | 1,854,557.39 | 2,004,304.08 | 2,562,954.67 |
| 存货 | 41,498,781.04 | 45,798,426.86 | 57,081,131.9 | 52,323,040.59 |
| 其他流动资产 | 4,066,448.52 | 4,656,628.79 | 1,446,359.33 | 1,832,699.27 |
| 流动资产合计 | 220,539,380.5 | 194,412,064.5 | 217,008,513.62 | 222,713,693.72 |
| 非流动资产: | | | | |
| 固定资产 | 158,011,835.2 | 160,803,593.93 | 163,682,467.6 | 167,026,123.77 |
| 在建工程 | 13,252,874.17 | 9,093,268.1 | 1,831,487.52 | 1,253,350.94 |
| 使用权资产 | 16,322,940.99 | 17,711,435.11 | 22,669,615.33 | 24,577,269.91 |
| 无形资产 | 5,080,159.3 | 5,099,221.2 | 5,049,312.21 | 5,088,010.11 |
| 商誉 | 1,614,611.74 | 1,614,611.74 | 1,614,611.74 | 1,614,611.74 |
| 长期待摊费用 | 8,897,070.77 | 10,014,215.8 | 11,180,526.76 | 12,053,763.24 |
| 递延所得税资产 | 6,008,434.53 | 5,958,537.42 | 7,182,984.38 | 7,136,414.26 |
| 非流动资产合计 | 209,187,926.7 | 210,294,883.3 | 213,211,005.54 | 218,749,543.97 |
| 资产总计 | 429,727,307.2 | 404,706,947.8 | 430,219,519.16 | 441,463,237.69 |
| 流动负债: | | | | |
| 短期借款 | 156,180,940 | 132,563,243.75 | 124,824,940 | 126,886,706.77 |
| 应付票据及应付账款 | 73,544,433.21 | 77,601,637.42 | 83,478,663.56 | 88,629,705.78 |
| 其中：应付票据 | 2,964,570.48 | 8,325,632.84 | 8,951,357.65 | 6,388,763.05 |
| 应付账款 | 70,579,862.73 | 69,276,004.58 | 74,527,305.91 | 82,240,942.73 |
| 合同负债 | 3,320,372.04 | 2,356,005.07 | 4,392,383.84 | 2,454,063.03 |
| 应付职工薪酬 | 3,457,494.16 | 2,915,292.44 | 2,999,217.92 | 3,909,658.31 |
| 应交税费 | 6,888,422.79 | 4,343,460.18 | 14,407,384.25 | 15,659,645.82 |
| 其他应付款合计 | 21,507,387.57 | 19,766,084.8 | 29,871,753.1 | 35,019,264.5 |
| 应付股利 | 23,403.36 | 23,403.36 | 23,403.36 | 23,403.36 |
| 一年内到期的非流动负债 | 8,004,538.56 | 7,532,027.5 | 10,410,354.4 | 13,570,923.12 |
| 其他流动负债 | 425,644.65 | 299,737.4 | 537,607.85 | 252,313.67 |
| 流动负债合计 | 273,329,232.98 | 247,377,488.56 | 270,922,304.92 | 286,382,281 |
| 非流动负债: | | | | |
| 租赁负债 | 9,386,653.38 | 9,590,275.4 | 13,131,763.29 | 10,335,472.84 |
| 预计负债 | 476,367.66 | 476,367.66 | 948,080.59 | 948,080.59 |
| 递延收益 | 48,157,342.82 | 49,648,225.66 | 51,140,027.29 | 52,634,184.46 |
| 递延所得税负债 | 4,080,735.26 | 4,427,858.78 | 6,117,678.86 | 6,144,317.49 |
| 非流动负债合计 | 62,101,099.12 | 64,142,727.5 | 71,337,550.03 | 70,062,055.38 |
| 负债合计 | 335,430,332.1 | 311,520,216.06 | 342,259,854.95 | 356,444,336.38 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 121,778,885 | 121,778,885 | 121,778,885 | 121,778,885 |
| 资本公积 | 162,787,915.98 | 162,787,915.98 | 162,787,915.98 | 162,787,915.98 |
| 盈余公积 | 24,181,414.37 | 24,181,414.37 | 24,181,414.37 | 24,181,414.37 |
| 未分配利润 | -242,155,533.95 | -246,116,521.81 | -251,270,022.51 | -256,364,330.55 |
| 归属于母公司股东权益合计 | 66,592,681.4 | 62,631,693.54 | 57,478,192.84 | 52,383,884.8 |
| 少数股东权益 | 27,704,293.7 | 30,555,038.2 | 30,481,471.37 | 32,635,016.51 |
| 股东权益合计 | 94,296,975.1 | 93,186,731.74 | 87,959,664.21 | 85,018,901.31 |
| 负债和股东权益合计 | 429,727,307.2 | 404,706,947.8 | 430,219,519.16 | 441,463,237.69 |
| 公告日期 | 2025-10-29 | 2025-08-28 | 2025-04-28 | 2025-04-01 |
| 审计意见(境内) | | | | 标准无保留意见 |